Breakthrough in Cancer Treatment: Fucoidan-Decorated Nanocomplexes Show Promising Results

Strategic Insights -

Scientists at Taipei Medical University have developed a novel nanosystem that targets metastatic tumor cells and enhances cancer immunotherapy. The research, published in the Journal of Nanobiotechnology, presents a multifunctional nanoplatform that combines metal ions, organic ligands, and fucoidan to suppress tumor growth and distant metastasis. The nanocomplexes were shown to induce ferroptotic cell death and enhance the therapeutic efficacy of immune checkpoint blockade therapy.

Key Takeaways:

  • The multifunctional nanoplatform, consisting of supramolecular assembled nanoparticles (SANs), was designed to target metastatic tumor cells and reinstate immune perception.
  • The SANs comprised a core structure of metal ion (Fe) and organic ligands, including tannic acid (TA) and zoledronic acid (Zol), which facilitated the releases of Zol in response to the acidic tumor microenvironment.
  • The Fe-TA-Zol coordination network enabled iron redox cycling, triggering ferritinophagy and ferroptotic-inducing activity accompanied by the induction of stimulator of interferon genes (STING) pathway.
  • The fucoidan-decorated nanocomplexes, denoted as FTZ@Fu, effectively attenuated the immunosuppressive tumor microenvironment and suppressed tumor growth and distant metastasis.
  • The researchers demonstrated that the FTZ@Fu nanocomplexes potentiated the therapeutic efficacy in combination with immune checkpoint blockade (ICB) therapy, showing promise as a targeted therapeutic strategy.

Statistics:

  • The research was financially supported by the National Science and Technology Council.
  • The Journal of Nanobiotechnology published the research in its 2025 issue (23(1):405).
  • The team of researchers included Chi Lin, Hsin-Ting Tsai, Chu-Hung Chung, Wen-Jing Hsu, Ming-Yi Hsieh, Ming-Cheng Chiang, Tzu-Wei Lu, Fwu-Long Mi, and Cheng-Wei Lin.

Sources:

  • Fucoidan-decorated metal-zoledronic acid nanocomplexes suppress tumor metastasis by inducing ferroptotic cell death and enhancing cancer immunotherapy. Journal of Nanobiotechnology, 2025;23(1):405.
  • Taipei Medical University Reports Findings in Cancer (Fucoidan-decorated metal-zoledronic acid nanocomplexes suppress tumor metastasis by inducing ferroptotic cell death and enhancing cancer immunotherapy). Nanotechnology Weekly. June 16, 2025; p 1907.